LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 1235 | 1359 | 4156 | 0.3270 | 0.0423 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 1235 | 1423 | 4156 | 0.3424 | 0.0642 |
MCF7 | Trametinib | 3.33 | uM | LJP5 | 1 | P20 | 72 | hr | 1235 | 2362 | 4156 | 0.5683 | 0.3857 |
MCF7 | Trametinib | 3.33 | uM | LJP5 | 2 | P20 | 72 | hr | 1235 | 2399 | 4156 | 0.5772 | 0.3984 |
MCF7 | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 1235 | 2162 | 4156 | 0.5202 | 0.3173 |
MCF7 | TWS119 | 3.33 | uM | LJP5 | 1 | M02 | 72 | hr | 1235 | 2621 | 4156 | 0.6306 | 0.4744 |
MCF7 | TWS119 | 3.33 | uM | LJP5 | 2 | M02 | 72 | hr | 1235 | 2678 | 4156 | 0.6443 | 0.4939 |
MCF7 | TWS119 | 3.33 | uM | LJP5 | 3 | M02 | 72 | hr | 1235 | 2596 | 4156 | 0.6246 | 0.4658 |
MCF7 | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 1235 | 4321 | 4156 | 1.0397 | 1.0564 |
MCF7 | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 1235 | 4092 | 4156 | 0.9846 | 0.9780 |
MCF7 | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 1235 | 4066 | 4156 | 0.9783 | 0.9691 |
MCF7 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 1235 | 1097 | 4156 | 0.2640 | -0.0474 |
MCF7 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 1235 | 1021 | 4156 | 0.2457 | -0.0734 |
MCF7 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 1235 | 987 | 4156 | 0.2375 | -0.0850 |
MCF7 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 1235 | 956 | 4156 | 0.2300 | -0.0957 |
MCF7 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 1235 | 1078 | 4156 | 0.2594 | -0.0539 |
MCF7 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 1235 | 1119 | 4156 | 0.2692 | -0.0398 |
MCF7 | WYE-125132 | 3.33 | uM | LJP6 | 1 | L08 | 72 | hr | 1235 | 1710 | 4156 | 0.4114 | 0.1625 |
MCF7 | WYE-125132 | 3.33 | uM | LJP6 | 2 | L08 | 72 | hr | 1235 | 1681 | 4156 | 0.4045 | 0.1526 |
MCF7 | WYE-125132 | 3.33 | uM | LJP6 | 3 | L08 | 72 | hr | 1235 | 1606 | 4156 | 0.3864 | 0.1269 |
MCF7 | WZ3105 | 3.33 | uM | LJP5 | 1 | D20 | 72 | hr | 1235 | 849 | 4156 | 0.2043 | -0.1323 |
MCF7 | WZ3105 | 3.33 | uM | LJP5 | 2 | D20 | 72 | hr | 1235 | 779 | 4156 | 0.1874 | -0.1563 |
MCF7 | WZ3105 | 3.33 | uM | LJP5 | 3 | D20 | 72 | hr | 1235 | 845 | 4156 | 0.2033 | -0.1337 |
MCF7 | XMD11-50 | 3.33 | uM | LJP6 | 1 | P08 | 72 | hr | 1235 | 1649 | 4156 | 0.3968 | 0.1416 |
MCF7 | XMD11-50 | 3.33 | uM | LJP6 | 2 | P08 | 72 | hr | 1235 | 1613 | 4156 | 0.3881 | 0.1293 |